Plant-based technology.
Rx results.

Our Flare & Repair Treatments are powered by Bw24, our patented plant technology that was shown in double-blind patient trials to reduce the symptoms of mild-to-moderate eczema, psoriasis, and inflamed skin.

Pharmaceutical-grade Patient Trials

We took a rigorous approach to testing the safety and efficacy of Bw24. Double-blind patient trials are often reserved for pharmaceutical drugs, but we also decided to go this route for our plant-based OTC formula.

Our double-blind studies for eczema and psoriasis

We currently have two double-blind patient studies (with one more to be released soon!): one that targeted mild-to-moderate eczema sufferers, and one that targeted mild-to-moderate psoriasis sufferers. Both showed clinically significant and very positive results.

Read our dermatologist fact sheet

Eczema

4 Weeks

found clinically meaningful reduction 45 in eczema severity (SCORAD)

12 Weeks

70% had 60% reduction in severity

Symptoms reduced:
redness, dryness, swelling, redness, flaking, oozing/crusting, scratch marks, skin thickening, 20 itch and sleeplessness.

Psoriasis

2 Weeks

significant reductions in symptoms compared to baseline

12 Weeks

70% reached 75% improvement

Better Than Rx

statistically significant improvements at 4, 8, and 12-weeks compared to Rx (Calcipotriol)

Symptoms reduced:
redness, dryness, swelling, redness, flaking, oozing/crusting, scratch marks, skin thickening, itch and sleeplessness.
Ready to explore?
Start your journey
to flare-free skin
Read Jamie's Story
Take The Skin Quiz

What Is Bw24?

16
ingredients extracted and diffused in traditional botanical methods (with no essential oils);
08
ingredients extracted and micro-dosed using homeopathic methods (with no essential oils).
24
curated botanicals in Bw24

Chosen for their properties of treating the symptoms of eczema, psoriasis, and sensitive skin, Bw24 is a patented botanical blend.

These extracts have origins in both eastern and western plant-based medicine.

Our Ingredients

Achillea Millefolium, Aesculus Hippocastanum, Althaea Officinalis Root Extract, Avena Sativa (Oat) Seed Extract, Berberis Vulgaris, Cochlearia Officinalis Extract, Conium Maculatum, Hamamelis Virginiana (Witch Hazel) Extract, Lens Esculenta Fruit Extract, Malva Sylvestris (Mallow) Leaf Extract, Matricaria Chamomilla, Nasturtium Officinale Leaf Extract, Phytolacca Decandra, Pimpinella Saxifraga Extract, Populus Alba Bark Extract, Populus Tremuloides Bark Extract, Rhus Toxicodendron, Sambucus Nigra Extract, Sanguinaria Canadensis, Scrophularia Nodosa Extract, Smilax Medica Extract, Tussilago Farfara (Coltsfoot) Leaf Extract, Veronica Officinalis Extract, Vincetoxicum Hirundinaria Root Extract

Yarrow
Achillea Millefolium
European horse-chestnut
Aesculus Hippocastanum
Marsh mallow
Althaea Officinalis
Oat
Avena Sativa
Barberry
Berberis Vulgaris
Scurvygrass
Cochlearia Officinalia
Poison hemlock
Conium Maculatum
American witch-hazel
Hamamelis Virginiana
Lentil
Lens Esculenta
High Mallow
Malva Sylvestris
German chamomile
Matricaria Chamomilla
Watercress
Nasturtium Officinale
American pokeweed
Phytolacca Decandra
Burnet-saxifrage
Pimpinella Saxifraga
White poplar
Populus Alba
Quaking aspen
Populus Tremuloides
Poison ivy
Rhus Toxicodendron
Elderberry
Sambucus Nigra
Bloodroot
Sanguinaria Canadensis
Figwort
Scrophularia Nodosa
Sarsaparilla
Smilax Medica
Coltsfoot
Tussilago Farfara
Heath speedwell
Veronica Officinalis
White Swallow-wort
Vincetoxicum Hirundinaria

Our Dermatologist Leadership Team

Tiffany Mayo, M.D. is a board-certified dermatologist and Assistant Professor of Dermatology at The University of Alabama at Birmingham. She received an undergraduate and master’s degree in Chemistry at Tuskegee University. Dr. Mayo completed her medical degree from Baylor College of Medicine and Dermatology training at The University of Alabama at Birmingham. She is the Director of Dermatology Clinical Research and her clinical interests include skin of color, inflammatory diseases, including atopic dermatitis and psoriasis, and hair and scalp disorders.

Peter Lio, M.D. is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Lio received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and a founding partner of Medical Dermatology Associates of Chicago. He currently serves as a board member and scientific advisory committee member for the National Eczema Association and has over 150 publications and two textbooks.

Smita Aggarwal, M.D. is a board-certified dermatologist and board-certified pediatric dermatologist. She received her medical degree from the University of Kansas, completed her Dermatology training at Loyola University Medical Center in Chicago, followed by a Pediatric Dermatology fellowship at Lurie Children’s Hospital, affiliated with Northwestern University. She is a Fellow of the American Academy of Dermatology, member of the Chicago Dermatological Society, and the Society for Pediatric Dermatology. Her clinical interests include autoimmune and inflammatory diseases in both the adult and pediatric population, with a focus on atopic dermatitis and psoriasis. She currently practices in downtown Chicago, where she aims to integrate both traditional and complementary treatments in her practice of medicine

Dr. Silverberg completed his undergraduate and medical school training as a part of the highly selective dual B.A./M.D. program at State University of New York Downstate Medical Center, in Brooklyn. He also received his doctorate in neuroimmunology and Master of Public Health degree in biostatistics and epidemiology from the State University of New York Downstate Medical Center.

Dr. Silverberg’s area of clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. His publications include more than 600 peer-reviewed articles, abstracts and book chapters and he is known internationally for his work.

He is also an associate editor for the Journal of the American Academy of Dermatology, British Journal of Dermatology and Current Dermatology Reports. Dr. Silverberg is a member of the International Eczema Council, North American Contact Dermatitis Group the American Society of Contact Dermatitis. Dr. Silverberg is also the chair of the annual Revolutionizing Atopic Dermatitis global multidisciplinary conference.